Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/18/26 16:01 | 2/15/26 | TEVA | Health | Drug | Pharmaceutical Preparations | Francis Richard D | L3 | O | P,CEO | 1 | S.d | -15,325 | 34.22 | 0 | -448 | 606 | D | |||||||||||||||
12/18/25 16:04 | 12/16/25 | TEVA | Health | Drug | Pharmaceutical Preparations | Weiss Amir | L3 | O | Chief Ac | 1 | S | -372 | 30.20 | 0 | -12 | 6 | D | |||||||||||||||
12/18/25 16:02 | 12/16/25 | TEVA | Health | Drug | Pharmaceutical Preparations | Mignone Roberto | L3 | D | 2 | S | -3,642 | 28.59 | 0 | -127 | 550 | I | ||||||||||||||||
12/11/25 16:09 | 12/9/25 | TEVA | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | 1 | S.d | -3,311 | 28.68 | 0 | -115 | 48 | D | |||||||||||||||
12/11/25 16:06 | 12/9/25 | TEVA | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | See "Rem | 1 | S.d | -6,231 | 28.73 | 0 | -217 | 53 | D | |||||||||||||||
11/24/25 16:03 | 11/20/25 | TEVA | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,Head | 1 | S.d | -700 | 24.78 | 0 | -28 | 64 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |